Why is fair value unavailable for Stemtech Corp (OTC-STEK) stock?

A reliable fair value estimate is not currently available for Stemtech Corp (OTC-STEK). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

How is the financial health of Stemtech Corp?

The current financial health read for Stemtech Corp (OTC-STEK) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Stemtech Corp's next earnings date?

The next earnings date currently listed for Stemtech Corp (OTC-STEK) is November 19, 2026.

Does Stemtech Corp (OTC-STEK) pay dividends?

The latest available data indicates no current dividend yield for Stemtech Corp (OTC-STEK).

What is the market capitalization of Stemtech Corp?

The current market capitalization listed for Stemtech Corp is 299.703 K.

What is the enterprise value of Stemtech Corp?

The current enterprise value listed for Stemtech Corp is 4.497 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Stemtech Corp?

The ticker symbol for Stemtech Corp is OTC-STEK, and the stock is listed on OTC Markets.

Where is Stemtech Corp (OTC-STEK) listed?

Stemtech Corp (OTC-STEK) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Stemtech Corp?

The current debt-to-total-capital ratio listed for Stemtech Corp is 109.4%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Stemtech Corp?

The free float listed for Stemtech Corp is 98.5%. Free float helps investors understand how much of the share base is available for public trading.

Stemtech Corp (STEK) Fair Value & Stock Analysis

Stemtech Corp (STEK)

Stemtech Corp is a consumer staples company focused on stem cell nutrition and personal care products. Operating as common stock on the OTC Markets under the ticker STEK, the company develops science-based products intended to support healthy stem cell physiology. Its product range includes the rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, Collect One, and the Cellect One shield hypochlorous acid skin care product. Stemtech distributes its products through independent distributors and serves customers across the Americas, Latin America, and Asia. The company was founded in 2005 and is headquartered in Naples, Florida.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
OTC-STEK	Not available	Not available	Not available	Weak	0.0%	November 19, 2026	0.1x	299.703 K	4.497 M	109.4%	98.5%	-120.4	8.8%